ALHC Quote, Financials, Valuation and Earnings

Centene has a net margin of -0.98% compared to Alignment Healthcare's net margin of 2.81%. Alignment Healthcare's return on equity of -77.81% beat Centene's return on equity of 12.65%.

Alignment Healthcare has a consensus price target of $18.40, signalling upside risk potential of 37.42%. On the other hand Centene has an analysts' consensus of $54.74 which suggests that it could grow by 79.99%. Given that Centene has higher upside potential than Alignment Healthcare, analysts believe Centene is more attractive than Alignment Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Centene has a beta of 0.439, suggesting its less volatile than the S&P 500 by 56.078%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $926.9M, which are smaller than Centene quarterly revenues of $46.6B. Alignment Healthcare's net income of -$9.1M is lower than Centene's net income of $1.3B. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Centene's PE ratio is 4.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.86x versus 0.09x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health has a net margin of -0.98% compared to Alignment Healthcare's net margin of 9.04%. Alignment Healthcare's return on equity of -77.81% beat Oscar Health's return on equity of 10.83%.

Alignment Healthcare has a consensus price target of $18.40, signalling upside risk potential of 37.42%. On the other hand Oscar Health has an analysts' consensus of $14.99 which suggests that it could fall by -2.32%. Given that Alignment Healthcare has higher upside potential than Oscar Health, analysts believe Alignment Healthcare is more attractive than Oscar Health.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Oscar Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oscar Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Oscar Health pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $926.9M, which are smaller than Oscar Health quarterly revenues of $3B. Alignment Healthcare's net income of -$9.1M is lower than Oscar Health's net income of $275.3M. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Oscar Health's PE ratio is 54.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.86x versus 0.42x for Oscar Health. Usually stocks with elevated PS ratios are considered overvalued.

Progyny has a net margin of -0.98% compared to Alignment Healthcare's net margin of 4.65%. Alignment Healthcare's return on equity of -77.81% beat Progyny's return on equity of 11.16%.

Alignment Healthcare has a consensus price target of $18.40, signalling upside risk potential of 37.42%. On the other hand Progyny has an analysts' consensus of $26.25 which suggests that it could grow by 14.03%. Given that Alignment Healthcare has higher upside potential than Progyny, analysts believe Alignment Healthcare is more attractive than Progyny.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Progyny has a beta of 1.307, suggesting its more volatile than the S&P 500 by 30.703%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Progyny offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Progyny pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $926.9M, which are larger than Progyny quarterly revenues of $324M. Alignment Healthcare's net income of -$9.1M is lower than Progyny's net income of $15.1M. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Progyny's PE ratio is 40.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.86x versus 1.78x for Progyny. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of -0.98% compared to Alignment Healthcare's net margin of 5.74%. Alignment Healthcare's return on equity of -77.81% beat UnitedHealth Group's return on equity of 21.74%.

Alignment Healthcare has a consensus price target of $18.40, signalling upside risk potential of 37.42%. On the other hand UnitedHealth Group has an analysts' consensus of $380.75 which suggests that it could grow by 30.18%. Given that Alignment Healthcare has higher upside potential than UnitedHealth Group, analysts believe Alignment Healthcare is more attractive than UnitedHealth Group.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.449, suggesting its less volatile than the S&P 500 by 55.115%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 2.91% to investors and pays a quarterly dividend of $2.21 per share. Alignment Healthcare pays -- of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Alignment Healthcare quarterly revenues are $926.9M, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. Alignment Healthcare's net income of -$9.1M is lower than UnitedHealth Group's net income of $6.3B. Notably, Alignment Healthcare's price-to-earnings ratio is -- while UnitedHealth Group's PE ratio is 12.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 0.86x versus 0.66x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.